DEA Schedule III Registration for Cannabis Extraction Manufacturers: Forms, Fees, Facility Requirements, and the Compliance Gap

DEA Schedule III cannabis manufacturer registration requires DEA Form 225 with drug codes 7362 (marijuana extract), 7353 (tetrahydrocannabinols), or 7386 (marijuana). Annual fee: $3,699 for manufacturers. The 60-day priority filing window from the April 28, 2026 Federal Register final order closes June 26-27, 2026. Operators who file within that window receive a guaranteed 6-month DEA review and “pending protection” allowing continued operations under their state license while the application processes. Operators who miss the window face the standard DEA registration timeline with no guaranteed review period and no interim protection.

If you hold a state extraction license right now, that license is necessary but not sufficient for federal compliance. State C1D1 classification covers fire and explosion hazard. DEA registration adds diversion controls, federal inventory requirements, a nominal price crop mechanism you have never dealt with, and a pre-registration on-site inspection by your local DEA Field Office. The two frameworks address different risks, and the gap between them is where most operators will fail their first inspection.

Who Needs to Register and Who Does Not

DEA created four registration categories for state-licensed medical cannabis businesses. Each corresponds to a specific activity and annual fee:

Adult-use-only operators do not qualify. This registration pathway is exclusively for state-licensed medical cannabis businesses. If your facility handles both medical and adult-use cannabis, you can register for the medical side, but you must maintain strict operational segregation: separate inventory tracking, separate financial records, separate physical storage, and separate documentation. Adult-use cannabis remains Schedule I under federal law. Commingling medical and adult-use inventory in the same vault or on the same production line creates a federal felony exposure that your state license does not protect you from.

Recreational-only facilities in states without medical programs are completely outside this pathway. If your state does not have a medical cannabis program or you only hold an adult-use license, DEA registration is not available to you under the current framework.

The 60-Day Priority Window: Why It Matters and What Happens If You Miss It

The final order was published in the Federal Register on April 28, 2026. DEA established a 60-day priority filing window that closes around June 26-27, 2026 (sources vary by one day on the exact cutoff). The difference between filing inside and outside that window is significant:

The pending protection is the critical detail. An operator who files within the window can continue running their extraction lab under their state license while DEA processes the application. An operator who files late has no guaranteed protection during the review period. That creates a legal gray zone where you are handling a Schedule III controlled substance without a valid federal registration and without the safety net of a pending application filed within the expedited pathway.

The dispensary portal launched April 29, 2026. Nearly 400 businesses registered within the first three days. The manufacturer, distributor, and lab portals are still listed as “coming soon.” If you are waiting for the manufacturer portal to go live before filing, watch DEA’s Diversion registration page daily. The window does not pause because a portal is delayed.

What DEA Form 225 Requires: The 7 Disclosure Sections

The dispensary registration portal provides the best preview of what the manufacturer form will require. The application collects information across seven sections:

1. Personal and business information. Legal entity name, EIN, physical address of the registered location (must match where controlled substances are handled), responsible individual, and authorized users.
2. Ownership structure. Every person with ownership interest, partnership stakes, or signing authority. This is more granular than most state applications. DEA wants to know who controls the entity, not just who runs the operation.
3. State licenses held. You must provide proof of a valid state medical cannabis license. DEA’s expedited pathway requires this before they process anything. No state license, no federal registration.
4. Supplier identification. For manufacturers, this means identifying your upstream cultivator or distributor. For extractors purchasing crude or biomass, you need to name your licensed supplier and their DEA registration number (once they have one).
5. Security infrastructure. Description of your physical security measures: vault/safe specifications, alarm systems, surveillance coverage, access controls. For Schedule III manufacturers, 21 CFR 1301.72 requires a “securely locked, substantially constructed cabinet” for storage. Larger quantities require an alarm that reports to a central protection company or 24-hour law enforcement monitoring.
6. Criminal history. Personal background disclosure for all individuals listed in the application. DEA can deny registration based on felony drug convictions or other relevant criminal history under 21 U.S.C. 823.
7. Activity-specific details. For manufacturers: production methods, product types, estimated annual production quantities (by drug code), and waste disposal procedures for cannabis waste.

The Gap Between State C1D1 and Federal DEA Requirements

This is where most extraction operators underestimate the work. Your state C1D1 classification addresses one risk: fire and explosion hazard from flammable solvents. DEA registration addresses a completely different risk: diversion of controlled substances. Passing your state inspection does not mean you pass a DEA inspection. The two frameworks look at different things.

The bottom line: your state license proves you can handle solvents safely. Your DEA registration proves you can handle controlled substances without diversion. Those are two different tests. An extraction lab with a perfect C1D1 classification can still fail a DEA pre-registration inspection if the storage does not meet 1301.72 cabinet specifications, if the alarm system does not report to a central monitoring station, or if the waste disposal process follows state protocol but not 21 CFR 1317.

DEA Pre-Registration Inspections: What to Expect

Your local DEA Field Office may conduct an on-site inspection before approving your manufacturer registration. This is not guaranteed for every applicant, but DEA has the authority to require it and has been exercising that authority since the dispensary portal opened. If your application raises questions or if you are in a high-volume market, expect a visit.

The inspection focuses on:

• Physical security verification. Does the storage match what you described in the application? Is the cabinet substantially constructed? Is the alarm system connected and reporting to a central station? Are access controls actually controlling access?
• Diversion controls. Can you demonstrate chain-of-custody from receiving raw material to shipping finished product? Can you account for every gram of cannabis in your facility at any given time?
• Record accessibility. Can you produce your METRC data, batch records, COAs, and manifests within a reasonable timeframe? “The records are in our state system” is fine only if you can pull and present them on site.
• Waste handling. How do you currently dispose of cannabis waste? If you are using a state-approved method that does not involve a DEA-registered reverse distributor or a two-witness destruction with DEA Form 41, you have a gap.
• Employee access controls. Who has access to stored cannabis? Is the access list documented? Are background checks on file for all personnel?

Once registered, DEA inspection authority is ongoing. This is not a one-time gate. Federal inspectors can visit your facility at any time under the standard DEA diversion control inspection regime. There is no published inspection frequency, but if you are flagged for inventory discrepancies or if your market experiences enforcement attention, expect increased scrutiny.

The June 29 Hearing and What It Means for Your Registration

On June 29, 2026, DEA begins an administrative hearing at its Arlington, Virginia facility. This hearing runs through July 15 and addresses a separate, broader question: whether ALL forms of marijuana (not just medical and FDA-approved) should be rescheduled from Schedule I to Schedule III. This proceeding is based on an executive order signed December 18, 2025.

This is not the same action that moved state-licensed medical cannabis to Schedule III on April 28. That final order is already in effect. The June 29 hearing is about extending Schedule III status to all marijuana, including adult-use.

For extraction operators, the practical impact is:

• If you hold a medical license: Nothing changes about your registration obligation. The April 28 final order is active. File your Form 225 before the priority window closes.
• If you are adult-use only: This hearing matters to you. If the ALJ recommends rescheduling all marijuana to Schedule III, adult-use operators would eventually need DEA registration too. Watch the hearing outcome, but do not wait for it to act on your medical registration if you hold both licenses.
• If you hold both medical and adult-use: Register the medical side now within the priority window. Keep the adult-use side operationally segregated. If the hearing results in broader rescheduling, you will already have a DEA relationship and registration infrastructure in place.

Compliance Gap Checklist: What to Fix Before You File

Run this checklist against your current facility before submitting your Form 225. Every item you cannot check off is a potential inspection failure.

Common Failures and How to Avoid Them

Based on the early dispensary registrations and the requirements published so far, these are the failure modes extraction operators are most likely to encounter:

Failure 1: Filing after the priority window closes.
Consequence: No pending protection. You are operating with a Schedule III substance and no valid federal registration or pending application within the expedited pathway. Your state license does not protect you from federal enforcement.
Fix: File within the window. If the manufacturer portal is not live by June 25, contact DEA Diversion directly and ask about paper filing options or an extension for the manufacturer category.

Failure 2: Assuming state C1D1 compliance equals DEA compliance.
Consequence: Pre-registration inspection failure. DEA inspector finds your storage does not meet 1301.72, your alarm does not report to a central station, or your waste disposal follows state but not federal protocol.
Fix: Run the checklist above. Address every gap before filing. A failed pre-registration inspection delays your approval and flags your facility for additional scrutiny.

Failure 3: Commingling medical and adult-use inventory.
Consequence: Federal felony exposure. Adult-use cannabis is still Schedule I. If your extraction equipment processes both medical and adult-use biomass without strict operational segregation, you are manufacturing a Schedule I substance on a Schedule III registration. That is not a compliance issue. That is a criminal liability issue.
Fix: Physically separate or temporally separate. Different storage, different batch records, ideally different processing days if you cannot physically divide the lab space.

Failure 4: No waste disposal relationship with a DEA-registered reverse distributor.
Consequence: Inspection finding. You generate cannabis waste daily (trim, spent biomass, failed batches, expired product). If you cannot demonstrate a DEA-compliant disposal pathway, your operation has an unresolvable compliance gap.
Fix: Identify and contract with a DEA-registered reverse distributor in your state. If none exist yet (this is a new market), establish a two-witness on-site destruction protocol with DEA Form 41 documentation ready to file.

Failure 5: Cannot produce records on demand during an inspection.
Consequence: DEA concludes you cannot demonstrate adequate diversion controls. This is one of the grounds for registration denial under 21 U.S.C. 823.
Fix: Export your METRC data and batch records to a local, accessible format. Have manifests, COAs, and production logs organized by batch with physical or instant-access digital copies at the facility. “It is in the cloud” is not an answer DEA accepts when they are standing in your lab.

If you want to understand how lab layout, ventilation design, and safety equipment factor into both state C1D1 and federal DEA requirements, we cover the full design and buildout workflow in our extraction training course at extractiontraining.com.

Timeline: What to Do This Week

If you are a state-licensed medical cannabis extraction operator, here is your action sequence:

1. This week (before June 27): Check DEA Diversion’s registration page daily for the manufacturer portal launch. If it goes live, file immediately. If it does not launch before the window closes, contact your local DEA Field Office and document that you attempted to file within the window.
2. This week (regardless of portal status): Run the compliance gap checklist above. Identify and begin fixing every gap. Cabinet upgrade, alarm contract, reverse distributor relationship, records export protocol.
3. Within 30 days of registration: Conduct your initial physical inventory per 21 U.S.C. 827. This is a complete count of all cannabis and cannabis products at your registered location. It must reconcile with your METRC records.
4. Ongoing: Maintain biennial (every 2 years) federal inventories. Keep all records DEA-accessible. Maintain operational segregation if dual-licensed.

Frequently Asked Questions

Do I need a DEA registration if I only have an adult-use cannabis license?

No. The current DEA registration pathway is exclusively for state-licensed medical cannabis businesses. Adult-use cannabis remains Schedule I under federal law. If you hold only a recreational or adult-use extraction license, DEA registration is not available or required. The June 29 hearing addresses whether this might change, but it has not changed yet.

What are the DEA drug codes for cannabis extraction?

Three drug codes apply to cannabis manufacturers on DEA Form 225: 7362 (marijuana extract, covers concentrates and extracts), 7353 (tetrahydrocannabinols, covers THC-specific products), and 7386 (marijuana, covers flower and raw plant material). Most extraction labs will need 7362 and possibly 7353 depending on product types.

How much does DEA manufacturer registration cost?

Annual fee is $3,699 for manufacturers. Analytical labs pay $296/year. Distributors pay $1,850/year. Dispensaries pay $794/year. These are federal fees in addition to your existing state license fees.

What happens if I miss the 60-day priority window?

You lose the guaranteed 6-month review timeline and the “pending protection” that allows continued operations under your state license while the application is processed. Filing after the window means operating in a legal gray zone during the standard (unspecified) DEA review timeline. The priority window closes around June 26-27, 2026.

Does my state C1D1 compliance satisfy DEA requirements?

No. State C1D1 addresses fire and explosion hazard from flammable solvents per NFPA 30 and IFC. DEA requirements address controlled substance diversion under 21 CFR Parts 1301, 1304, and 1317. The two frameworks cover different risks. You need both. A C1D1-compliant lab can fail a DEA inspection if storage cabinets, alarm monitoring, waste disposal, or recordkeeping do not meet federal specifications.

Will DEA inspect my facility before approving my registration?

Possibly. DEA has the authority to conduct pre-registration on-site inspections and has been exercising that authority since the dispensary portal opened. Your local DEA Field Office decides based on the application, the market, and the facility. Treat it as likely and prepare accordingly. The inspection focuses on storage security, diversion controls, record accessibility, waste handling, and employee access documentation.

Can I use my METRC data to satisfy DEA recordkeeping?

DEA has stated it will accept state-required records (METRC tracking, transport manifests, lab COAs) “to the maximum extent permissible.” The requirement is that records must be DEA-accessible, meaning you can produce them on-demand during an inspection. Export your METRC data to a local format and keep physical or instantly accessible digital copies at the facility. Cloud-only access with slow export speeds is a risk.

What is the nominal price crop mechanism?

This is a Single Convention treaty obligation with no state-level analog. Manufacturers must establish a nominal price for harvested marijuana crop and store it in a DEA-accessible facility until a paper transaction is completed. This is entirely new for cannabis operators. You will need SOPs and accounting procedures that your state has never required. DEA guidance on implementation details is still developing.

Ready to level up your extraction game? Contact WKU Consulting for personalized guidance on building your extraction lab.

For more deep dives into cannabis chemistry, extraction SOPs, and lab design, subscribe to the WKU Consulting YouTube channel.

See also: Cannabis Schedule III Reclassification: What Changes for Extraction Labs for the full policy overview of what Schedule III means for 280E, banking, and research access.

For state-specific extraction licensing requirements, fees, and facility standards: Cannabis Extraction License Requirements by State (2026)